Trump administration bars use of Medicaid funds for some youth transgender care

President Trump's administration has decided to cease Medicaid and the Children's Health Insurance Program (CHIP) from covering gender-affirming surgeries and hormone treatments for transgender minors. This decision marks a continuation of a series of policies targeting transgender individuals since Trump's return to office last year. The extent of the financial impact on transgender youth's healthcare remains uncertain, with no response from the Centers for Medicare and Medicaid Services to inquiries about the policy.

At least 27 states have already enacted bans on gender-affirming care for individuals under 18, and numerous prominent hospitals have halted providing certain treatments. Gender-affirming surgeries for minors are relatively infrequent; more common are puberty blockers and hormone treatments. The policy stipulates that Medicaid and CHIP will continue to fund mental health treatment for transgender minors but will gradually withdraw coverage for hormone treatments that serve dual purposes of puberty inhibition and sex-related physical modifications for those already receiving them as of April 2027.

In a social media post, Trump directed CMS Administrator Dr. Mehmet Oz to implement the change, stating, "We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies." LGBTQ+ advocacy groups refute the administration's stance, viewing it as erecting obstacles for parents making the best medical decisions for their children.

HRC President Kelley Robinson vowed to challenge the rule in court, condemning the administration's actions as terrifying for transgender youth and their families. Major medical organizations, including the American Medical Association, generally support access to gender-affirming care, although the American Society of Plastic Surgeons has expressed insufficient evidence regarding the benefits of certain surgeries for minors experiencing gender dysphoria.

The administration has also targeted transgender athletes in sports competitions, restricted gender designation on passports, and released a report favoring therapy-based treatment over comprehensive gender-affirming healthcare for transgender youth. Most changes have encountered legal challenges, with the Supreme Court upholding the passport policy, a lower court rejecting the unsafe and ineffective treatment declaration, and a hospital policy case still pending.